This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Studies on Three Hundred Thirty-Six Patients

PAUL HELLER, M.D.; HYMAN J. ZIMMERMAN, M.D.

AMA Arch Intern Med. 1956;97(4):403-408.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The L. E. cell phenomenon has been considered to be highly specific for systemic lupus erythematosus.* Nevertheless, it has been reported in isolated cases of other diseases and has been repeatedly demonstrated in association with severe hypersensitivity reactions to penicillin, tetanus antitoxin, hydantoin,¹⁰ and hydralazine.

The resulting hypothesis that the L. E. cell might represent an immunologic phenomenon led to the attempt to reproduce it by incubating leucocytes with antileucocytic rabbit serum.|| The cells thus produced resembled, but were not identical with, the L. E. cell. The inclusion body was still recognizable as a secondary nucleus with preserved chromatin pattern, in contrast to the "smoky" homogenized L. E. inclusion body. Patients with hypersensitivity states frequently may show such nucleophagocytosis ¹⁷ and occasionally the L. E. cell phenomenon.¶ Zimmer and Hargraves ¹⁸ noted that positive L. E. preparations in patients with systemic lupus erythematosus showed increased numbers of nucleophagocytes . . . [Full Text PDF of this Article]

Author Affiliations
Chicago With the Technical Assistance of Vivian J. Mega, Chicago

From the Department of Medicine of the Veterans Administration West Side Hospital and the University of Illinois College of Medicine.

Footnotes
Submitted for publication Sept. 23, 1955.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?